Neurosteroids: Endogenous modulators of neuronal excitability and plasticity

Neurology

Volumn 68, Issue 12, 2007, Pages 945-947

  Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DIAZEPAM; FLUMAZENIL; NEUROPROTECTIVE AGENT; NEUROSTEROID; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE SULFATE;

ALZHEIMER DISEASE; BRAIN INJURY; CATAMENIAL EPILEPSY; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DENTATE GYRUS; EPILEPTOGENESIS; GABAERGIC TRANSMISSION; GLIA CELL; HEPATIC ENCEPHALOPATHY; HUMAN; MENTAL DISEASE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT SURVEY; STEROID METABOLISM; STEROIDOGENESIS;

EID: 34147192546     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000257836.09570.e1     Document Type: Article

References (16)

1. Baulieu EE. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998;23:963-987.
2. Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 2005;6:565-575.
3. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 2002;13:35-43.
4. Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 2004;62:99-118.
5. Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem Int 2006;49:372-378.
6. Genedani S, Rasio G, Cortelli P, et al. Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients. Neurotox Res 2004;6:327-332.
7. Marx CE, Trost WT, Shampine LJ, et al. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. Biol Psychiatry 2006.
8. Griffin LD, Gong W, Verot L, Mellon SH. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 2004;10:704-711.
9. Guarneri P, Cascio C, Russo D, et al. Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration. Ann NY Acad Sci 2003;1007:117-128.
10. Garcia-Ovejero D, Azcoitia I, Doncarlos LL, Melcangi RC, Garcia-Segura LM. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res Brain Res Rev 2005;48:273-286.
11. Pisu MG, Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci 2004;74:3181-3197.
12. Strous RD, Maayan R, Weizman A. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur Neuropsychopharmacol 2006;16:155-169.
13. Dubrovsky BO. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:169-192.
14. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann NY Acad Sci 2003;1007:64-78.
15. Dudas B, Hanin I, Rose M, Wulfert E. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid. Neurobiol Dis 2004;15:262-268.
16. Wolkowitz OM, Kramer JH, Reus VI, et al. DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology 2003;60:1071-1076.